Image 1
Finasteride Tablet, Film Coated
Product Images NDC 0093-7355
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Finasteride (NDC 0093-7355). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
Image 3
Image 4
This looks like a table summarizing the percent change from a baseline measurement over four years for two groups, one taking a placebo and the other taking Finasteride. However, without additional context or a description of what is being measured, it's hard to say more than that.*
Image 5
The text describes a graph labeled as "Figure 5" which shows the cumulative incidence of a 4-point rise in AUA symptom score by treatment group. The graph shows percentages on the y-axis and years from randomization on the x-axis. The treatment groups are not described in the given text.*
Image 6
Usual adult dosage for an unidentified medication is 5mg taken once a day. The medication should be stored within the temperature range of 20°C to 25°C (68°F to 77°F). The users should keep the medication out of the reach of children. The given text may belong to a medication label or prescription. No further information is available.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
